Reply to T.U. Hoogenraad's paper published last April. Zinc therapy in Wilson's disease.
Marcellini
Matilde
M
Sartorelli
Maria Rita
MR
Nobili
Valerio
V
D002648:Child; D003300:Copper / Q000037:antagonists & inhibitors* / Q000652:urine; D003315:Cornea / Q000473:pathology / Q000503:physiopathology; D006527:Hepatolenticular Degeneration / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects / Q000502:physiology; D020127:Recovery of Function / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome; D014202:Tremor / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D019287:Zinc Sulfate / Q000627:therapeutic use*
D019287:Zinc Sulfate; D003300:Copper